NEW: Redenlab commence work with Royal Melbourne Hospital on mobile speech recording in multiple sclerosis

In collaboration with the Movement Disorders and Cognitive monitoring in MS group. Speech is being used as an outcome measure in a treatment trial for Tremor in MS.

Tags: , , ,

Related Post

Understanding speech and language in KIF1A-associated neurological disorder

  • Posted on 17 June, 2025
    A new study published in the European Journal of Human Genetics provides the first systematic analysis of speech and language...
    Read more

    Redenlab contributes to position paper on advancing digital healthtechnologies for frontotemporal degeneration

    • Posted on 15 May, 2025
      MEDIA RELEASE MELBOURNE, VIC – A major collaborative paper published in Alzheimer’s & Dementia introduces a critical roadmap for the...
      Read more

      Redenlab announces landmark study in collaboration with Queensland Institute of Medical Research

      • Posted on 11 December, 2024
        MEDIA RELEASE Melbourne - December 2024 – Redenlab, a leader in innovative healthcare solutions, has partnered with the Queensland Institute of Medical...
        Read more